Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Fatty Acids Supplement + Nasal Steroids for Allergic Rhinitis
NCT07016763Phase 1Completed
- Sponsor
- Gemelli Isola Hospital
- Start
- Sep 2024
- Primary completion
- Mar 2025
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial (2 arms), sponsored by Gemelli Isola Hospital. Primary endpoints: Endoscopic evaluation at 90 days, Visual Analogue Scale at 90 days and 1 more. Started Sep 2024; status: completed.
Beyond the preview
Go deeper on NCT07016763.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07016763.